Treatment Goals of Depressed Outpatients

Battle, Cynthia L.; Uebelacker, Lisa A.; Friedman, Michael; Cardemil, Esteban V.; Beevers, Christopher G.; Miller, Ivan W.

doi:10.1097/01.pra.0000390763.57946.93

Cited by 36 publications

(14 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite a substantial heterogeneity in goal formulation within the same diagnostic group (Grawe, 2004;Michalak & Grosse Holtforth, 2006;Trachsel, Itten, Stauffer, Grosse Holtforth, & Hofer, 2008), several studies support the notion that contents of treatment goals are partly diagnosis-specific (Berking, Grosse Holtforth, Jacobi, & Kröner-Herwig, 2004;Grosse Holtforth & Grawe, 2002;Grosse Holtforth, Wyss, Schulte, Trachsel, & Michalak, 2009): Specifically, patients with anxiety disorders show a preference for problem-or symptom-focused goals, whereas patients who suffer from depression seem to be characterized by a thematically more heterogeneous goal structure with an additional focus on interpersonal goals (Grosse Holtforth & Grawe, 2002) and functional improvement (Battle et al, 2010). Dirmaier, Harfst, Koch, and Schulz (2006) report similar findings with regard to anxiety and depressive disorders as well as specific and distinct differences between patients with dependency or adjustment disorders and patients with other diagnoses.…”

Section: Patient Goals In Psychotherapy Researchmentioning

confidence: 92%

Relevance of therapy goals in outpatient cognitive-behavioral and psychodynamic psychotherapy

Schöttke

Trame

Sembill

2014

Psychotherapy Research

View full text Add to dashboard Cite

show abstract

Section: Patient Goals In Psychotherapy Researchmentioning

confidence: 92%

Relevance of therapy goals in outpatient cognitive-behavioral and psychodynamic psychotherapy

Schöttke

Trame

Sembill

2014

Psychotherapy Research

View full text Add to dashboard Cite

show abstract

“…This method of analysis is consistent with qualitative coding techniques described by Crabtree and Miller 33 and has been used in prior research examining patient preferences for treatment. 34 …”

Section: Methodsmentioning

confidence: 99%

Perinatal Antidepressant Use

Battle

Salisbury

Schofield

et al. 2013

Journal of Psychiatric Practice

Self Cite

185

View full text Add to dashboard Cite

Perinatal depression is prevalent and linked with a host of adverse consequences for women and newborns. Rates of engagement in depression treatment are, however, strikingly low among pregnant and postpartum women, with the majority of affected women receiving no mental health treatment. Research indicates that perinatal women are extremely reluctant to take antidepressant medications, yet the nature of women’s concerns and treatment decisionmaking patterns have not been well documented. Developing a clearer understanding of women’s treatment preferences and behaviors may help identify solutions to the under-treatment of perinatal depression. In this mixed methods study, we conducted in-depth interviews with 61 pregnant women, approximately half of whom were experiencing clinical levels of depression. In addition to assessing psychiatric diagnoses, symptoms, and functional impairment, we conducted qualitative interviews addressing women’s preferences for depression treatment, concerns, and decision-making patterns. Consistent with prior reports, women were significantly more likely to voice a preference for non-pharmacologic depression treatments, as opposed to antidepressant medications. Many depressed women reported a great degree of uncertainty regarding how to treat their depression, and those with more severe depression symptoms were more likely to endorse decisional conflict. Analysis of qualitative comments yielded detailed information about the nature of women’s concerns and preferences related to use of antidepressant medications and other aspects of treatment engagement. We discuss findings in the context of improving patient-centered care for perinatal depression.

show abstract

“…Successful management of MDD necessitates shared decision-making between patients and healthcare providers (HCPs) to set appropriate treatment goals (19). However, available data suggest that patients and HCPs differ in their views as to what they consider important for recovery from MDD (20)(21)(22)(23). We have previously reported results of a large, international, online survey undertaken to assess potential differences in perceptions of MDD symptoms and treatment priorities between patients and HCPs across the different phases of the disease (23).…”

Section: Introductionmentioning

confidence: 99%

Symptoms of Major Depressive Disorder and Their Impact on Psychosocial Functioning in the Different Phases of the Disease: Do the Perspectives of Patients and Healthcare Providers Differ?

Christensen

Wong²,

Baune

2020

Front. Psychiatry

View full text Add to dashboard Cite

This analysis was undertaken to examine the relationship between different symptoms of major depressive disorder (MDD) and psychosocial functioning from the perspectives of patients and healthcare providers (HCPs) across the different phases of the disease (acute, post-acute, and remission). Data regarding symptoms of MDD and psychosocial functioning, assessed by an adapted version of the Functioning Assessment Short Test (FAST) scale, were elicited via an online survey from 2,008 patients diagnosed with MDD (based on their personal experience of the disease) and 3,138 patients observed by 1,046 HCPs (based on individual patient records). Correlations between patient-reported and HCP-reported MDD symptoms and impairment of psychosocial functioning were assessed by multivariate regression analysis. The population comprised 1,946 patient respondents and 3,042 HCP-reported patients. Patients reported experiencing a wider range of symptoms and greater impairment of functioning than reported by HCPs across all phases of the disease. At the domain level, only cognitive symptoms were found to be significantly associated with functioning during the acute phase from the perspective of patients, while from the HCPs' perspective both mood and cognitive symptoms significantly impacted functioning in this phase. Significant associations were seen between mood, physical, and cognitive symptom domains and functioning in both cohorts during the post-acute and remission phases. Differences in associations between individual MDD symptoms and functioning were also observed between the two cohorts across all disease phases; in particular, HCPs found that more physical symptoms impacted functioning during remission than did patients. In summary, the results suggest that perceptions of MDD symptoms and the associations between these symptoms and functioning differ significantly between patients and HCPs across all phases of the disease. These findings further highlight the need for improved

show abstract

Treatment Goals of Depressed Outpatients

Cited by 36 publications

References 28 publications

Relevance of therapy goals in outpatient cognitive-behavioral and psychodynamic psychotherapy

Relevance of therapy goals in outpatient cognitive-behavioral and psychodynamic psychotherapy

Perinatal Antidepressant Use

Symptoms of Major Depressive Disorder and Their Impact on Psychosocial Functioning in the Different Phases of the Disease: Do the Perspectives of Patients and Healthcare Providers Differ?

Contact Info

Product

Resources

About